Esperion Therapeutics, Inc. Collaboration Agreements
8 Contracts & Agreements
- 1st Amendment to License and Collaboration Agreement, by and between the Registrant and Daiichi Sankyo Company, Limited dated January 2, 2024 (Filed With SEC on May 7, 2024)
- 3rd Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated January 2, 2024 (Filed With SEC on May 7, 2024)
- License and Collaboration Agreement, by and between the Registrant and Daiichi Sankyo Company, Limited dated April 26, 2021 (Filed With SEC on August 3, 2021)
- 2nd Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated March 19, 2021 (Filed With SEC on May 4, 2021)
- 1st Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated June 18, 2020 (Filed With SEC on August 10, 2020)
- License and Collaboration Agreement by and between the Registrant and Otsuka Pharmaceutical Co., Ltd. dated April 17, 2020 (Filed With SEC on August 10, 2020)
- License and Collaboration Agreement by and between Daiichi Sankyo Europe GmbH and the Company, dated as of January 2, 2019 (Filed With SEC on February 28, 2019)
- Amendment to Collaboration & License Agreement (Filed With SEC on December 23, 2003)
